Jefferies believes aggressive moves by incumbents and entry of new players in the QC space can result in higher discounting ...
Jefferies analyst Daniel Fannon maintained a Buy rating on Goldman Sachs Group (GS – Research Report) today and set a price target of $667.00.
24/7 Wall St. on MSN4d
Jefferies Top 2025 Stock Picks Include 5 Sizzling Large Cap Dividend Blue ChipsThis post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions ...
Jefferies downgraded Blue Star Ltd. to 'hold' from 'buy' after the stock rallied 140% in calendar year 2024. The stock is now ...
Jefferies analyst Julien Dumoulin Smith reiterated a Buy rating on GE Vernova Inc. (GEV – Research Report) yesterday and set a price target of ...
24/7 Wall St. on MSN6d
Jefferies Adds 3 Growth and Dividend Superstars to Top Picks List for 2025Jefferies has made some changes to its well-respected Franchise Picks list. Three of its picks for 2025 look like outstanding ...
Topgolf Callaway stock rose Thursday after Jefferies analysts raised their rating on shares of the golf equipment ...
The yield on 10-year Bunds edged up and Jefferies said it had a buy level at 2.40%, so would prefer “a long position at [the] current level.” ...
Key stocks recommended by Jefferies for 2025 include Mankind Pharma, JB Chemicals, and Sun Pharmaceutical Industries.
The global brokerage firm revised the target lower, citing increasing competition as a threat to the online food aggregator’s ...
Newsable Asianet News on MSN9h
Instil Bio Stock Soars After Jefferies Upgrade On 'Early Mover' Cancer Drug Candidate: Retail JubilantInstil Bio’s stock surged over 25% on Tuesday to levels last seen in early December after Jefferies upgraded the shares to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback